Navigation Links
ACT Obtains Exclusive License for Hemangioblast Technology in North America
Date:7/21/2011

r of ACT.  "Hemangioblasts can be used to provide transfusable blood components, such as red blood cells and platelets, as well as cells capable of affecting vascular repair.  We hope that these programs will eventually help address the critical care shortage of blood for emergency situations. In addition, our preclinical research has shown the ability of hemangioblast-derived cells to repair vascular damage when administered systemically, offering potential therapeutic uses to treat vascular ischemic damage, ischemia-reperfusion injury, diabetic vascular disease and peripheral artery disease (PAD), which represent the leading causes of death and/or disability worldwide.  Indeed, in preclinical studies, these cells quickly repaired vascular damage, cutting the death rate after a heart attack in half and restoring the blood flow to ischemic limbs that might otherwise have required amputation."

The proprietary hemangioblast technology developed by SCRMI and ACT is uniquely well-suited for developing stem cell-based therapies because they are highly expandable and can consistently and reproducibly give rise to various cells of the hematopoietic (blood) and endothelial (vascular) lineages.  Strong clinical demand for donated platelets, for example, has stimulated interest in generating renewable sources of transfusable platelets.  In recent scientific publications, SCRMI scientists demonstrated that it is feasible to generate functional megakaryocytes and platelets from hESCs on a large scale.  The hESC-platelets displayed features that were indistinguishable from those of normal blood platelets, and participated in both clot formation and retraction in-vitro.

In September of last year, Dr. Lanza and Kwang-Soo Kim, Ph.D. (Harvard University/McLean Hospital and CHA Stem Cell Institute),

SOURCE Advanced Cell Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
3. Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
4. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
5. NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
6. Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss
7. Sinovac Biotech Co. Ltd., Sinovacs Beijing Subsidiary, Obtains High-Tech Enterprise Status
8. Occlutech Obtains Favourable Ruling in Proceedings Initiated by AGA Medical
9. Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
10. China Sky One Medical, Inc. Obtains SFDA Approvals for Geranium Ointment and Musk Liniment for Pain Relief
11. SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Dr. Greg Leyer of ... annual Scripps Natural Supplements Pre-Conference seminar on probiotics in San ... an annual continuing education conference for health care professionals. This ... the topic of probiotics in health. Dr. Leyer spoke about ...
(Date:1/22/2015)... 22 de enero de 2015  El Dr. Paul ... llamada a nominaciones para 2015. Este prestigioso premio reconoce ... tiene el potencial para hacer, contribuciones destacadas para la ... hasta el 15 de marzo de 2015 a través ...
(Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
(Date:12/24/2014)... Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   VRML), ... announced today that the Company closed its previously ... Management, Jack W. Schuler , Birchview Fund ... $10.5 million, before offering expenses.  The proceeds will ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... - Some of extraterrestrial expert Frank Drake s ... of 300 at the University of Wisconsin-Madison Feb. 19, ... in Mountain View, Calif., explained the reasons why he ... potential methods of communicating with far-off civilizations. , ,I ...
... DEMO and in the weeks since, I've been asked many ... networking. There is, of course, one very practical reason: No ... 2004 timeframe. But that's the easy out. , ,As I've ... fundamental sense. Without a clear avenue to revenue that returns ...
... majority of economists and corporate executives believe that globalization ... it causes. But there is a substantial difference between ... faire attitude towards how this trend affects businesses, communities ... assistant professor of public policy at Rochester Institute of ...
Cached Biology Technology:Alien expert illuminates audience on extraterrestrial possibilities 2Social Networks Revisited 2Social Networks Revisited 3Preservation not protectionism 2Preservation not protectionism 3
(Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) has announced ... Home Button Synaptics Fingerprint Sensor Technology Analysis" report ... Based on a totally different sensing ... first time a fingerprint sensor in its product. ...
(Date:12/17/2014)... is fundamentally transforming the travel experience and nowhere is ... past decade, ePassports, biometric readers, and secure document scanners ... control via eGates and Automated Passport Control (APC) Kiosks ... borders across the globe. According to ...
(Date:12/11/2014)... PAUL, Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... bear little resemblance to the IT technologies of 20 years ... more dramatic changes to our lives. To help determine the ... experts to join the Foresight 2030 Workshop: Harnessing the Digital ... The workshop the first in a series ...
... cancer has shown considerable promise in early clinical trials involving ... , Of 30 men who received low doses of one ... evaluate safety, 22 showed a sustained decline in the level ... clinical trials are planned to evaluate the drug,s effect on ...
... that has perplexed humanity since the dawn of time: does ... published in the April 2009 issue of the journal ... the United States and Australia discovered that at the genetic ... and that this compatibility plays an important role in mate ...
Cached Biology News:COST Foresight 2030 2New medications show promise in treating drug-resistant prostate cancer 2New medications show promise in treating drug-resistant prostate cancer 3New medications show promise in treating drug-resistant prostate cancer 4Is love at first sight real? Geneticists offer tantalizing clues 2
Bis-Acrylamide (bis) is a monomer used as a crosslinker with acrylamide to form polyacrylamide electrophoretic gels. This 2% bis solution is supplied as 500 ml....
... field separations of DNA larger than 2, ... megabase pairs. This agarose has the highest gel strength of any electrophoresis ... ... ...
... G|2 Doublestain System is a high-sensitivity ... kit. The kit is intended for ... detection of two different antigens within ... with suitably diluted rabbit and mouse ...
Liquid. PBS containing 10 mM NaN 3 . AVOID FREEZE/THAW CYCLES. Recognizes α1, 2, 3, 5, 6 and 7 subunits of 20S proteasome. ...
Biology Products: